Lee WM, Squires RH Jr, Nyberg SL, et al. Acute liver failure: summary of a workshop[J]. Hepatology, 2008, 47(4): 1401-1415.
[2]
Ostapowicz G, Lee WM. Acute hepatic failure: a Western perspective[J]. J Gastroenterol Hepatol, 2000, 15(5): 480-488.
[3]
Auzinger G, Wendon J. Intensive care management of acute liver failure[J]. Curr Opin Crit Care, 2008, 14(2): 179-188.
[4]
van de Kerkhove MP, Hoekstra R, Chamuleau RA, et al. Clinical application of bioartificial liver support systems[J]. Ann Surg, 2004, 240(2): 216-230.
[5]
Nussler A, Konig S, Ott M, et al. Present status and perspectives of cell-based therapies for liver diseases[J]. J Hepatol, 2006, 45(1): 144-159.
[6]
Stravitz RT. Critical management decisions in patients with acute liver failure[J]. Chest, 2008, 134(5): 1092-1102.
[7]
Chiu A, Fan ST. MARS in the treatment of liver failure: Controversies and evidence[J]. Int J Artif Organs, 2006, 29(7): 660-667.
[8]
Ekser B, Rigotti P, Gridelli B, et al. Xenotransplantation of solid organs in the pig-to-primate model[J]. Transpl Immunol, 2009, 21(2): 87-92.
[9]
Allen JW, Hassanein T, Bhatia SN. Advances in bioartificial liver devices[J]. Hepatology, 2001, 34(3): 447-455.
[10]
Li LJ, Du WB, Zhang YM, et al. Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigs[J]. J Hepatol, 2006, 44(2): 317-324.
[11]
Khan SA, Shah N, Williams R, et al. Acute liver failure: a review[J]. Clin Liver Dis, 2006, 10(2): 239-258.
[12]
Jalan R. Acute liver failure: current management and future prospects[J]. J Hepatol, 2005, 42 (Suppl 1): S115-S123.
[13]
Riordan SM, Williams R. Perspectives on liver failure: past and future[J]. Semin Liver Dis, 2008, 28(2): 137-141.
[14]
Tunon MJ, Alvarez M, Culebras JM, et al. An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure[J]. World J Gastroenterol, 2009, 15(25): 3086-3098.
[15]
Terblanche J, Hickman R. Animal-models of fulminant hepatic-failure[J]. Digest Dis Sci, 1991, 36(6): 770-774.
[16]
Fournea I. Potentially reversible model of acute liver failure in the pig. A model to test the efficiency of bioartificial liver[M]. Thesis: Leuven University Press, 2001: 41-56.
[17]
Filipponi F, Fabbri LP, Marsili M, et al. A new surgical model of acute liver failure in the pig: experimental procedure and analysis of liver injury[J]. Eur Surg Res, 1991, 23 (1): 58-64.
[18]
Nardo B, Tsivian M, Neri F, et al. Extracorporeal portal vein oxygenation improves outcome of acute liver failure in swine[J]. Transpl Proceed, 2008, 40(6): 2046-2048.
[19]
Chen XP, Xue YL, Li XJ, et al. Experimental research on TECA-I bioartificial liver support system to treat canines with acute liver failure[J]. World J Gastroenterol, 2001, 7(5): 706-709.
Rose C, Ytrebo LM, Davies NA, et al. Association of reduced extracellular brain ammonia, lactate, and intracranial pressure in pigs with acute liver failure[J]. Hepatology, 2007, 46(6): 1883-1892.
[22]
Yuasa T, Yamamoto T, Rivas-Carrillo JD, et al. Laparoscopy-assisted creation of a liver failure model in pigs[J]. Cell Transpl, 2008, 17(1-2): 187-193.
Chen Z, Ding YT. Functional evaluation of a new bioartificial liver system in vitro and in vitro[J]. World J Gastroenterol, 2006, 12(8): 1312-1316.
[25]
Francavilla A, Makowka L, Polimeno L, et al. A dog model for acetaminophen-induced fulminant hepatic failure[J]. Gastroenterology, 1989, 96(2): 470-478.
[26]
Kelly JH, Koussayer T, He DE, et al. An improved model of acetaminophen-induced fulminant hepatic failure in dogs[J]. Hepatology, 1992, 15 (2): 329-335.
[27]
Sielaff TD, Hu MY, Rollins MD, et al. An anesthetized model of lethal canine galactosamine fulminant hepatic failure[J]. Hepatology, 1995, 21 (3): 796-804.
[28]
Diaz-Buxo JA, Blumenthal S, Hayes D, et al. Galactosamine-induced fulminant hepatic necrosis in unanesthetized canines[J]. Hepatology, 1997, 25 (4): 950-957.
[29]
Kalpana K, Ong HS, Soo KC, et al. An improved model of galactosamine-induced fulminant hepatic failure in the pig[J]. J Surg Res, 1999, 82(2): 121-130.
[30]
Patzer JF, Mazariegos GV, Lopez R. Preclinical evaluation of the Excorp Medical, Inc, Bioartificial Liver Support System[J]. J Am Coll Surg, 2002, 195 (3): 299-310.
Zhang F, He YW, Duan ZP. Changes of high mobility group box 1 in serum of pig acute hepatic failure model and significance[J]. J Huazhong Univ Sci Technolog Med Sci, 2008, 28(1): 52-55.
Ishiguro S, Takada Y, Gu M, et al. Auxiliary partial orthotopic liver transplantation for fulminant hepatitis: regeneration of the diseased native iver in a pig model[J]. Transplantation, 2003, 75(11): 1901-1904.
[38]
Ishizawa Y, Totsuka E, Umehara M, et al. Efficacy of double-filtration plasmapheretic cross-circulation with a high-permeability membrane using canine harvested liver in porcine fulminant hepatic failure model[J]. Transpl Proceed, 2004, 36(8): 2344-2348.
[39]
Tunon MJ, Sanchez-Campos S, Garcia-Ferreras J, et al. Rabbit hemorrhagic viral disease: characterization of a new animal model of fulminant liver failure[J]. J Lab Clin Med, 2003, 141(4): 272-278.
[40]
San-Miguel B, Alvarez M, Culebras JM, et al. N-acetyl-cysteine protects liver from apoptotic death in an animal model of fulminant hepatic failure[J]. Apoptosis, 2006, 11(11): 1945-1957.
[41]
Stadbauer V, Jalan R. Acute liver failure: liver support therapies[J]. Curr Opin Crit Care, 2007, 13(2): 215-221.
[42]
Newsome PN, Plevris JN, Nelson LJ, et al. Animal models of fulminant hepatic failure: a critical evaluation[J]. Liver Transpl, 2000, 6(1): 21-31.
[43]
O’Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure[J]. Gastroenterology, 1989, 97(2): 439-445.
[44]
Rahman TM, Hodgson HJ. Animal models of acute hepatic failure[J]. Int J Exp Pathol, 2000, 81(2): 145-157.
[45]
Belanger M, Butterworth RF. Acute liver failure: a critical appraisal of available animal models[J]. Metab Brain Dis, 2005, 20(4): 409-423.
[46]
van de Kerkhove MP, Hoekstra R, van Gulik TM, et al. Large animal models of fulminant hepatic failure in artificial and bioartificial liver support research[J]. Biomaterials, 2004, 25(9): 1613-1625.
[47]
Filipponi F, Boggi U, Meacci L, et al. A new technique for total hepatectomy in the pig for testing liver support devices[J]. Surgery, 1999, 125(4): 448-455.
[48]
Sosef MN, Abrahamse LS L, van de Kerkhove MP, et al. Assessment of the AMC-bioartificial liver in the anhepatic pig[J]. Transplantation, 2002, 73(2): 204-209.
[49]
Sosef MN, van Gulik TM. Total hepatectomy model in pigs: revised method for vascular reconstruction using a rigid vascular prosthesis[J]. Eur Surg Res, 2004, 36(1): 8-12.
Knubben K, Thiel C, Schenk M, et al. A new surgical model for hepatectomy in pigs[J]. Eur Surg Res, 2008, 40(1): 41-46.
[52]
Fruhauf NR, Oldhafer KJ, Westermann S, et al. Acute hepatic failure in swine: hepatectomy versus vascular occlusion[J]. J Invest Surg, 2004, 17(3): 163-171.
[53]
Ferko A, Plodr M, Dobes D, et al. Sharp transsection of the parenchyma in liver resection[J]. Rozhl Chir, 2003, 82(8) : 407-412.
[54]
Topp SA, McClurken M, Lipson D, et al. Saline-linked surface radiofrequency ablation: factors affecting steam popping and depth of injury in the pig liver[J]. Ann Surg, 2004, 239(4): 518-527.
[55]
Ladurner R, Hochleitner B, Schneeberger S, et al. Extended liver resection and hepatic ischemia in pigs: a new, potentially reversible model to induce acute liver failure and study artificial liver support systems[J]. Eur Surg Res, 2005, 37(6): 365-369.
[56]
Fukueda M, Ishizaki N, Hamada N, et al. Porcine model of auxiliary partial orthotopic liver transplantation for acute liver failure[J]. Transplantation, 2006, 82(10): 1312-1318.
[57]
Ytrebo LM, Nedredal GI, Langbakk B, et al. An experimental large animal model for the assessment of bioartificial liver support systems in fulminant hepatic failure[J]. Scand J Gastroenterol, 2002, 37(9): 1077-1088.
[58]
Nakazawa K, Ijima H, Fukuda J, et al. Development of a hybrid artificial liver using polyurethane foam/hepatocyte spheroid culture in a preclinical pig experiment[J]. Int J Artif Organs, 2002, 25(1): 51-60.
[59]
Kieslichova E, Ryska M, Pantoflieek T, et al. Hemodynamic parameters in a surgical devascularization model of fulmi nant hepa tic failure in the minipig[J]. Physiol Res, 2005, 54(50): 485-490.
[60]
Nieuwoudt M, Kunnike R, Smuts M, et al. Standardization criteria for an ischemic surgical modelof acute hepatic failure in pigs[J]. Biomaterials, 2006, 27(20): 3836-3845.
[61]
Gao Y, Mu N, Xu XP, et al. Porcine acute liver failure model established by two-phase surgery and treated with hollow fiber bioartificial liver support system[J]. World J Gastroenterol, 2005, 11(35): 5468-5474.
[62]
Sen S, Rose C, Ytrebo LM, et al. Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study[J]. Crit Care Med, 2006, 34(1): 158-164.
[63]
Ekse S, Clapp LH, Revhaug A, et al. Endotheliumderived hyperpolarization factor (EDHF) is up-regulated in a pig model of acute liver failure[J]. Scand J Gastroenterol, 2007, 42(3): 356-365.
[64]
Arkadopoulos N, Vlhakos D, Kostopanagiotou G, et al. Iron chelation attenuates intracranial pressure and improves survival in a swine model of acute liver failure[J]. Liver Transpl, 2008, 14(8): 1116-1124.
